Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis

Keyphrases

• Myocarditis 100%
• Immune Checkpoint Inhibitors 100%
• Noncardiac 28%
• Cardiac Biomarkers 28%
• Cardiac Troponin 28%
• Creatinine Phosphokinase 28%
• Clinical Management 14%
• Defining Characteristic 14%
• Highly Sensitive 14%
• High Mortality Rate 14%
• Myocardial Injury 14%
• Patient Management 14%
• Blood Biomarkers 14%
• Unique Pattern 14%
• Myositis 14%
• Creatine Phosphokinase 14%
• Troponin 14%
• Rapid Progression 14%
• Severe Outcomes 14%
• Symptom Presentation 14%
• Screening Biomarker 14%
• Immune Checkpoint Inhibitor Myocarditis 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Myocarditis 100%
• Immune Checkpoint Inhibitor 100%
• Troponin 37%
• Phosphotransferase 25%
• Creatinine 25%
• Mortality Rate 12%
• Heart Muscle Injury 12%
• Creatine Kinase 12%
• Myositis 12%

Biochemistry, Genetics and Molecular Biology

• Immune Checkpoints 100%
• Phosphotransferase 25%
• Kinase 25%
• Cardiac Troponin 25%
• Creatinine 25%
• Mortality Rate 12%
• Troponin 12%
• Creatine Kinase 12%